147 related articles for article (PubMed ID: 33757755)
1. Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer.
Altuntaş OM; Süslü N; Güler Tezel YG; Tatlı Doğan H; Yılmaz T
Braz J Otorhinolaryngol; 2022; 88(6):968-974. PubMed ID: 33757755
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M
Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
[TBL] [Abstract][Full Text] [Related]
4. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
Le QT; Harris J; Magliocco AM; Kong CS; Diaz R; Shin B; Cao H; Trotti A; Erler JT; Chung CH; Dicker A; Pajak TF; Giaccia AJ; Ang KK
J Clin Oncol; 2009 Sep; 27(26):4281-6. PubMed ID: 19667273
[TBL] [Abstract][Full Text] [Related]
5. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
6. The possibilities of LOXL4 as a prognostic marker for carcinomas.
Wang J; Chen C; Huang J; Xie Z; Chen X; Zheng Z; Li E; Zou H
Amino Acids; 2023 Nov; 55(11):1519-1529. PubMed ID: 37814029
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase expression in bronchogenic carcinoma.
Woznick AR; Braddock AL; Dulai M; Seymour ML; Callahan RE; Welsh RJ; Chmielewski GW; Zelenock GB; Shanley CJ
Am J Surg; 2005 Mar; 189(3):297-301. PubMed ID: 15792754
[TBL] [Abstract][Full Text] [Related]
8. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.
Kasashima H; Yashiro M; Okuno T; Miki Y; Kitayama K; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
Digestion; 2018; 98(4):238-248. PubMed ID: 30045039
[TBL] [Abstract][Full Text] [Related]
9. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
11. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
12. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
13. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
14. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
[TBL] [Abstract][Full Text] [Related]
16. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
[TBL] [Abstract][Full Text] [Related]
17. LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer.
Choi SK; Kim HS; Jin T; Moon WK
Oncotarget; 2017 Feb; 8(7):11977-11989. PubMed ID: 28060764
[TBL] [Abstract][Full Text] [Related]
18. Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.
Lee YS; Park Y; Kwon M; Roh JL; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2017 Mar; 156(3):489-497. PubMed ID: 28116994
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
Kim EK; Cho YA; Koh YW; Shin HA; Cho BC; Yoon SO
BMC Cancer; 2020 Apr; 20(1):348. PubMed ID: 32326908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
